The Enterprise Value as of December 2025 (TTM) for Nykode Therapeutics AS (NYKD.OL) is 12.03M

According to Nykode Therapeutics AS’s latest financial reports and current stock price. The company's current Enterprise Value is 12.03M. This represents a change of -211.27% compared to the average of -10807062.41 of the last 4 quarters.

Nykode Therapeutics AS (NYKD.OL) Historical Enterprise Value (quarterly & annually)

How has NYKD.OL Enterprise Value performed in the past?

The mean historical Enterprise Value of Nykode Therapeutics AS over the last ten years is 1.37B. The current 12.03M Enterprise Value has changed -12.20% with respect to the historical average. Over the past ten years (40 quarters), NYKD.OL's Enterprise Value was at its highest in in the June 2020 quarter at 1.87B. The Enterprise Value was at its lowest in in the September 2022 quarter at -1595757710.61.

Nykode Therapeutics AS (NYKD.OL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nykode Therapeutics AS Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nykode Therapeutics AS (NYKD.OL) Average Enterprise Value

How has NYKD.OL Enterprise Value performed in the past?

The current Enterprise Value of Nykode Therapeutics AS (NYKD.OL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nykode Therapeutics AS (NYKD.OL) Enterprise Value vs. Peers

How is NYKD.OL’s Enterprise Value compared to its peers?

Nykode Therapeutics AS’s Enterprise Value is less than Hofseth BioCare ASA (562.31M), less than Lytix Biopharma AS (658.74M), less than Gentian Diagnostics ASA (768.05M), greater than BerGenBio ASA (-20176449.00), less than Navamedic ASA (608.62M), less than Arctic Bioscience AS (156.62M), greater than PCI Biotech Holding ASA (-3928750.00), less than Thor Medical ASA (1.28B), less than ArcticZymes Technologies ASA (851.63M), less than ContextVision AB (publ) (217.15M),

Build a custom stock screener for Nykode Therapeutics AS (NYKD.OL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nykode Therapeutics AS using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nykode Therapeutics AS (NYKD.OL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nykode Therapeutics AS or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.